๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
NCT07066657Locally Advanced or Metastatic Solid Tumors, Colorectal Cancer, Gastric Cancer, Pancreatic Cancer
ArriVent BioPharma, Inc.
Phase 1
572
Beijing, Chongqing, Zhejiang, Heilongjiang, Zhengzhou, Wuhan, Changsha, Shandong
2025-07-25
Recruiting
Tislelizumab Combined With Anlotinib and Nab-paclitaxel in III Resectable Non-small Cell Lung Cancer : A Prospective, Single-Arm, Phase II Study
NCT07089199NSCLC, Tislelizumab, Anlotinib, Nab-paclitaxel
Qilu Hospital of Shandong University
Phase 2
34
Jinan
2025-07-25
Recruiting
Shanghai Clinical Cohort - Adrenal Disease
NCT07191951Adrenal Disease
Shanghai Jiao Tong University School of Medicine
Observational
600
Shanghai
2025-07-25
Recruiting
A Phase III Study Evaluating the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity
NCT06974851Bstructive Sleep Apnea (OSA) and Obesity
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 3
140
Beijing
2025-07-25
Recruiting
Efficacy and Safety of HRS9531 in Participants With Type 2 Diabetes Treated With Basal Insulin
NCT07060456Type 2 Diabetes
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 3
300
Beijing
2025-07-25
Recruiting
Atmospheric Pressure Cold Plasma for Moderate-to-severe Tinea Pedis
NCT07056660Tinea Pedis
Shenyang Medical College
Not applicable
220
Luoyang
2025-07-25
Recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
NCT07037433Atherosclerotic Cardiovascular Disease, Overweight, Obesity
Amgen
Phase 3
12,800
Bengbu, Beijing, Guangzhou, Huizhou, Yulin, Qinhuangdao, Shijiazhuang, Harbin
2025-07-25
Recruiting
BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + Surgery/SBRT for BCLC-C HCC With PVTT and/or Oligometastases
NCT07062055Hepatocellular Carcinoma, Portal Vein Tumor Thrombus, Oligometastases, Radiotherapy
Shandong Cancer Hospital and Institute
Phase 2
54
Jinan
2025-07-25
Recruiting
ROS-Scavenging Nanozyme Combined With Thermotherapy Alleviate Radiation Dermatitis in Patients With Head and Neck Cancer
NCT07086638Radiation Dermatitis
West China Hospital
Not applicable
5
Chengdu
2025-07-25
Recruiting
Laser-assisted Ultrasound-guided Peripheral Vein Cannulation in Cardiac Surgery
NCT07079904Ultrasonography, Interventional
Nanjing First Hospital, Nanjing Medical University
Not applicable
100
Nanjing
2025-07-24
Recruiting
Efficacy of Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Bridging Therapy Followed by Transplantation in Higher-Risk Myelodysplastic Syndrome Patients
NCT06918834Myelodysplastic Syndromes
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
236
Beijin, Zhengzhou, Jinan, Chengdu, Shijia Zhuang
2025-07-24
Recruiting
Short-term Bactericidal Effect of Contezolid in MAC-PD
NCT07084402Mycobacterium Avium Complex Pulmonary Disease
Bin Cao
Phase 4
188
Beijing, Nanchang
2025-07-24
Recruiting
a Safety, Tolerability, and Pharmacokinetic Trial of Multiple Subcutaneous Injections of B1344 Injection in Patients With Nonalcoholic Fatty Liver Disease๏ผˆNAFLD๏ผ‰
NCT07128797NAFLD (Non-alcoholic Fatty Liver Disease), NASH (Nonalcoholic Steatohepatitis)
Tasly Biopharmaceuticals Co., Ltd.
Phase 1
32
Beijing, Guangzhou, Datong, Tianjin, Wenzhou
2025-07-24
Recruiting
Phase I/II Clinical Study of SHR-1501 Combined With Adbelizumab in Patients With Malignant Tumors
NCT07073534Patients With Advanced or Metastatic Malignant Tumors
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 1/2
203
Guangzhou
2025-07-24
Recruiting
Single-arm, Prospective Study of the Efficacy and Safety of PaitelingยฎAntibacterial Liquid in the Treatment of Persistent Cervical HR-HPV Infection
NCT07493824Persistent HR-HPV Infection of the Cervix
The First Hospital of Jilin University
Phase 4
115
Changchun
2025-07-24
Recruiting
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
NCT06807268Eczema
Pfizer
Phase 3
150
Beijing, Shenzhen, Changsha, Nanchang, Shanghai, Hangzhou
2025-07-24
Recruiting
Short-term Antibiotic Therapy in Mycobacterium Avium Complex Pulmonary Disease
NCT07213765Mycobacterium Avium Complex Pulmonary Disease
Bin Cao
Phase 4
188
Hefei, Beijing, Guangzhou, Nanchang, Shanghai
2025-07-24
Recruiting
Prevention of Recurrence With Cordyceps Sinensis in Mycobacterium Avium Complex Pulmonary Disease
NCT07174076Mycobacterium Avium Complex Pulmonary Disease
Bin Cao
Phase 4
300
Hefei, Beijing, Guangzhou, Nanchang, Shanghai
2025-07-24
Recruiting
A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.
NCT07203404SLE, LN, ANCA Associated Vasculitis, ANCA-Associated Glomerulonephritis
Nanjing Bioheng Biotech Co., Ltd.
Phase EARLY_PHASE1
96
Shanghai
2025-07-24
Recruiting
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
NCT06757634Breast Cancer
Celcuity Inc
Phase 3
1,180
2025-07-24
Recruiting
To Evaluate the Efficacy, Safety and Population Pharmacokinetics of GST-HG141 in Patients With Chronic Hepatitis B (CHB) Who Have an Inadequate Response to Antiviral Drug Treatment
NCT07090759Chronic Hepatitis b
Fujian Akeylink Biotechnology Co., Ltd.
Phase 3
526
Hangzhou
2025-07-24
Recruiting
A Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/ Refractory Plasma Cell Leukemia
NCT06730256Relapsed/Refractory Plasma Cell Leukemia, Relapsed/Refractory Multiple Myeloma
The First Affiliated Hospital of Soochow University
Phase EARLY_PHASE1
24
Suzhou
2025-07-23
Recruiting
ROS-scavenging Amino Acid-derived Lipids for the Prevention and Treatment of Radiation Dermatitis in Patients With Head and Neck Cancer
NCT07081074Radiation Dermatitis
West China Hospital
Not applicable
40
Chengdu
2025-07-23
Recruiting
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
NCT06758401Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
Pfizer
Phase 3
714
Hefei, Beijing, Fuzhou, Guangzhou, Huizhou, Nanning, Harbin, Luoyang
2025-07-23
Recruiting
A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer
NCT07024173Locally Advanced Breast Cancer, Metastatic Breast Cancer
Shandong Suncadia Medicine Co., Ltd.
Phase 3
240
Guangzhou, Changsha
2025-07-23
Recruiting
Effects of Environmental Fungal Exposure on Bronchial Asthma, ABPA and Bronchiectasis
NCT07313904Environmental Exposure, Asthma, Bronchiectasis, ABPA
First Affiliated Hospital of Ningbo University
Observational
125
Ningbo
2025-07-23
Recruiting
Chinese Migrant Population Health Cohort
NCT07124949Cardiovascular Diseases, Metabolic Disorders, Ageing and Geriatric Health, Climate Adaptation
Jinwei Tian
Observational
26,000
Harbin
2025-07-23
Recruiting
Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial (TRIUNITE-05)
NCT07165847Immunotherapy, Gastric Cancer (GC), Radiotherapy, Neoadjuvant Therapy
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 2
40
Chongqing
2025-07-23
Recruiting
Prediction of Postoperative Recurrence in Crohn's Disease
NCT07824791Crohn Disease (CD), Postoperative Recurrence and Metastasis
Sixth Affiliated Hospital, Sun Yat-sen University
Observational
250
Guangzhou
2025-07-22
Not yet open
A Study of mRNA Vaccines AK154 Monotherapy or in Combination With AK104/AK112,and Sequential mFOLFIRINOX in Surgically Resected PDAC
NCT06913218Pancreas Cancer, Pancreas Cancer, Duct Cell Adenocarcinoma
Akeso
Phase 1
60
Shanghai
2025-07-22
Recruiting
Prospective Cohort Study on Oral Microbiome Changes in Patients With Locally Advanced Oral Squamous Cell Carcinoma Following Neoadjuvant Chemoimmunotherapy
NCT07111455Locally Advanced Oral Squamous Cell Carcinoma
Zhujiang Hospital
Observational
32
Guangzhou
2025-07-22
Not yet open
Microscopic Varicocele Bypass Versus Ligation
NCT07065695Varicocele
Ke Dou
Not applicable
284
Chengdu
2025-07-22
Recruiting
A Clinical Study of SHR-4506 Injection in Patients With Malignant Tumors
NCT07068932Malignant Tumors of Adults
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1
102
Shanghai
2025-07-22
Active, closed
A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer
NCT07071714Colorectal Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 2
103
Guangzhou
2025-07-22
Recruiting
EASi-PROTKTโ„ข - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT07064473Diabetes Mellitus, Type 2, Hypertension, Cardiovascular Diseases
Boehringer Ingelheim
Phase 3
11,800
Baotou, Beijing, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Dalian
2025-07-22
Recruiting
Psychological Distress in Malignant Tumor Patients: Effects on Treatment Adherence, Outcomes, and Quality of Life
NCT07193329Psychological Distress, Malignant Tumor
Gang Chen, MD
Observational
2,000
Wenzhou
2025-07-22
Recruiting
A Early Study of ABSK131 in Patients With Advanced/Metastatic Solid Tumors
NCT07288957Solid Tumors (Phase 1)
Abbisko Therapeutics Co, Ltd
Phase 1
266
Shanghai
2025-07-22
Recruiting
Treatment of Clonorchiasis in Guangxi With Albendazole, Tribendimidine, and Praziquantel
NCT07074444Clonorchiasis
First Affiliated Hospital of Guangxi Medical University
Phase 4
318
Nanning
2025-07-22
Recruiting
A Phase I/II Study of HY05350 in Mesothelin(MSLN)-Positive Advanced Solid Tumors
NCT07083323Advanced Solid Tumor
Sichuan Huiyu Pharmaceutical Co., Ltd
Phase 1/2
262
Beijing
2025-07-22
Recruiting
A Multi-center Study on Artificial Intelligence-Based Quantitative Evaluation of Echocardiography
NCT07133516Artificial Intelligence (AI), Artificial Intelligence (AI) in Diagnosis, Cardiovascular Diseases (CVD), Echocardiography
First Hospital of China Medical University
Observational
1,600
Huainan, Fuzhou, Meizhou, Shantou, Shenzhen, Baise City, Guilin, Liuzhou
2025-07-22
Recruiting
MHB018A Treatment in Patients With Active Thyroid Eye Disease
NCT06989918Thyroid Associated Ophthalmopathies
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 3
108
Shanghai
2025-07-22
Recruiting
Efficacy and Safety of Cold Atmospheric Plasma Combined With Endovascular Intervention in Patients With Diabetic Foot Ulcers and Lower Extremity Arterial Occlusion
NCT07073040Diabetic Foot Ulcers (DFU), Lower Extremity Arterial Occlusion
Shenyang Medical College
Not applicable
86
Anshan
2025-07-22
Recruiting
Incidence of 106TBL Lymph Node Metastasis
NCT07165210Esophageal Cancer
Fudan University
Observational
1,852
Shanghai
2025-07-21
Recruiting
Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC
NCT06841172OligoProgressive Metastatic Disease, Hepatocellular Carcinoma (HCC), Radiotherapy, Systemic Therapy
Shandong Cancer Hospital and Institute
Phase 3
132
Jinan
2025-07-21
Recruiting
[18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis
NCT07232459Amyloid, Cardiac Amyloidosis, Amyloidosis, Healthy Subjects
Tianjin Medical University
Observational
25
Hefei, Qingdao, Tianjin
2025-07-21
Recruiting
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
NCT06943755Pancreatic Neuroendocrine Tumor (pNET), Extra-Pancreatic Neuroendocrine Tumor (epNET)
Exelixis
Phase 2/3
440
Hong Kong
2025-07-21
Recruiting
MRgLITT for mTLE: A PROBE Trial
NCT06720922Temporal Lobe Epilepsy (TLE)
Beijing Tiantan Hospital
Not applicable
120
Beijing
2025-07-21
Recruiting
Discovery and Validation of Periodontitis Biomarkers
NCT07293481Periodontitis, Biomarker in Early Diagnosis, Saliva
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Observational
228
Shanghai
2025-07-21
Recruiting
Erythrocytapheresis for Chronic Mountain Sickness
NCT04557995Chronic Mountain Sickness
Third Military Medical University
Not applicable
112
Xigazรช
2025-07-21
Recruiting
Modified Diagnosis and Treatment of Neonatal Hemolysis With ETCOc in sNH
NCT06832800Neonatal Hyperbilirubinemia
Women's Hospital School Of Medicine Zhejiang University
Phase EARLY_PHASE1
250
Hangzhou
2025-07-21
Recruiting
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
NCT07060807Breast Neoplasms
Merck Sharp & Dohme LLC
Phase 3
1,000
Hefei, Beijing, Chongqing, Wanzhou, Fujian, Guangzhou, Jiangmen, Nanning
2025-07-21
By invitation
Paclitaxel Polymeric Micelles and Carboplatin in Combination With Iparomilimab and Tuvonralimab Neoadjuvant Therapy for Triple-negative Breast Cancer๏ผˆUPGRADE-TNBC๏ผ‰
NCT06910072Triple-Negative Breast Cancer (TNBC), Neoadjuvant Therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2/3
32
Beijing
2025-07-21
Recruiting
A Phase I/โ…ก Human Study of HY0001a for Injection in Adult Participants With Advanced Solid Tumors
NCT07069062Solid Tumor
Sichuan Huiyu Pharmaceutical Co., Ltd
Phase 1/2
261
Beijing
2025-07-21
Recruiting
Incidence of 107 Lymph Node Metastasis
NCT07165184Esophageal Cancer
Fudan University
Observational
1,100
Shanghai
2025-07-21
Recruiting
Endotherapy and/or Extracorporeal Shockwave Lithotripsy for Painless Chronic Pancreatitis
NCT07074379Painless Chronic Pancreatitis
Changhai Hospital
Not applicable
126
Shanghai
2025-07-21
By invitation
Exploratory Trial of VR Intervention on Neuroplasticity in Older Adults With Cognitive Frailty
NCT07183033Cognitive Frailty
Peking Union Medical College
Not applicable
15
Beijing
2025-07-21
Recruiting
Combination of Concurrent Chemoradiotherapy With Surufatinib and Tislelizumab in Patients With Locally Advanced Non-Small Cell Lung Cancer
NCT07086456Surufatinib, Tislelizumab, Concurrent Chemoradiotherapy, Consolidation Therapy
Sun Yat-sen University
Phase 2
80
Guangzhou
2025-07-20
Not yet open
Inverted-ฮฉ Anastomosis in Laparoscopic Duodenum-Preserving Pancreatic Head Resection or Laparoscopic Central Pancreatectomy
NCT07087392Pancreatic Cystic Neoplasms
West China Hospital
Not applicable
20
Chengdu
2025-07-20
Not yet open
Perioperative Tislelizumab Plus Chemotherapy Versus Chemotherapy Alone in MHC-II-Positive Gastric/GEJ Cancer
NCT07068516Gastric Cancer Stage
Xiangdong Cheng
Phase 3
470
Hangzhou
2025-07-20
Recruiting
CAR-T Cells Therapy for Patients With Autoimmune Diseases
NCT07052565Autoimmune Diseases
Anhui Provincial Hospital
Not applicable
18
Hefei
2025-07-20
By invitation
The Effectiveness of Different Therapeutic Jaw Position Determining Methods in Repositioning Splint Therapy for Temporomandibular Joint Disk Displacement Without Reduction๏ผšA Randomized Controlled Clinical Trial
NCT07090772Temporomandibular Disorder (TMD)
Fujian Medical University
Not applicable
45
Fuzhou
2025-07-20
Recruiting
The Efficacy and Safety Assessment of Allogeneic ฮณฮด T Cells in Patients With MRD-positive AML After Allo-HSCT
NCT07126782AML (Acute Myelogenous Leukemia), AML
Institute of Hematology & Blood Diseases Hospital, China
Phase EARLY_PHASE1
10
Beijing
2025-07-20
Recruiting
Dyadic Personalized Home-Based Activity Program for Mild-to-Moderate Dementia Patients Post-Discharge
NCT07081750Dementia
Fujian Medical University
Not applicable
55
Fujian
2025-07-20
Not yet open
Individualized rTMS Synchronized Task Training for Closed-loop Neuromodulation of Post-stroke Motor Dysfunction
NCT07049211Upper Extremity Dysfunction After the Stroke
Ruijin Hospital
Not applicable
51
Shanghai
2025-07-20
Active, closed
Study on the Application of Adaptive Fluidics Technology in Lens Diseases Surgery
NCT07062107Lens Diseases
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
320
Hangzhou
2025-07-20
Active, closed
A Study on the Safety, Preliminary Efficacy, and Cellular Kinetics of Allo-CD7 CAR-T Cells in T1DM
NCT07142161Type 1 Diabetes
Nanjing Bioheng Biotech Co., Ltd.
Phase EARLY_PHASE1
3
Nanjing
2025-07-20
Recruiting
Surufatinib in Combination With Neoadjuvant Chemo-immunotherapy and Concurrent Chemoradiotherapy for Patients With Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma
NCT07086469Toripalimab, Surufatinib, Neoadjuvant Immunochemotherapy, Chemoradiotherapy
Sun Yat-sen University
Phase 2
69
Guangzhou
2025-07-20
By invitation
Safety and Efficacy of Chocolate Balloon Catheter in Peripheral Arterial Disease (CHOCO-PAD)
NCT06933992Peripheral Arterial Disease
First People's Hospital of Hangzhou
Observational
171
Hangzhou
2025-07-20
Not yet open
Study of Peripheral Blood CHI3L1 to Predict Tumor Response to Radiotherapy
NCT07071688Tumor, Radiotherapy, Biomarker
Nanfang Hospital, Southern Medical University
Observational
338
Guangzhou, Huizhou, Meizhou
2025-07-20
Not yet open
Irinotecan Liposomes in Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer
NCT07074353Locally Advanced Rectal Cancer
Zhejiang Cancer Hospital
Phase 3
360
Hangzhou
2025-07-20
Recruiting
A Clinical Study on the Safety and Tolerability of PL54 Injection in Adult Patients With Phenylketonuria (PKU)
NCT07672756Phenylketonuria (PKU)
Chongqing Peg-Bio Biopharm Co., Ltd.
Phase 1
48
Hefei
2025-07-20
Recruiting
REFINE-HCM: Intramyocardial Septal Radiofrequency Ablation for Obstructive Hypertrophic Cardiomyopathy
NCT07006493Hypertrophic Cardiomyopathy, Obstructive
SuZhou Sinus Medical Technologies Co.,Ltd
Not applicable
124
Beijing, Hangzhou
2025-07-20
Recruiting
Natural History Study of Inherited Retinal Diseases
NCT07085533Retinal Dystrophies, Color Vision Defects, Vision Disorders, Macular Degeneration
Zhongmou Therapeutics
Observational
200
Wuhan
2025-07-20
Not yet open
Efficacy and Safety of UCBT With TMI -Based Conditioning Regimen for Adults With Refractory/Relapsed Aplastic Anemia
NCT07078721Aplastic Anemia Idiopathic
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
11
Tianjin
2025-07-20
Not yet open
Efficacy and Safety of AK112 Combined Chemotherapy as Neoadjuvant Treatment for Signet Ring Cell-containing G/GEJ Adenocarcinoma
NCT07091227Gastric or Gastroesophageal Junction Adenocarcinoma
Peking Union Medical College Hospital
Phase 2
66
Beijing
2025-07-20
Not yet open
The Effect of Bupivacaine Liposome Preemptive Analgesia on Postoperative Pain and Delirium in Elderly Patients Undergoing Hip Fracture Surgery
NCT07066111Postoperative Delirium
Nanjing First Hospital, Nanjing Medical University
Phase 4
40
Nanjing
2025-07-20
Not yet open
GnRH Agonist Pretreatment Duration and Letrozole Supplementation in Frozen Embryo Transfer for Adenomyosis Patients
NCT07065539Adenomyosis of Uterus, Frozen Embryo Transfer (FET)
First Affiliated Hospital, Sun Yat-Sen University
Not applicable
432
Guangzhou
2025-07-20
Not yet open
Correlation of Dry Eye Disease, Problematic Smartphone Use and Sleep Quality in Adolescents and Young Adults
NCT07020871Dry Eye Disease (DED)
Wei XIA, PhD
Observational
453
Guangzhou
2025-07-20
Recruiting
Efficacy and Safety of Disitamab Vedotin Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer๏ผša Phase II Study
NCT07093866mCRPC
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2
20
Nanjing
2025-07-20
Not yet open
A Prospective, Single-arm, Phase II Clinical Study of Tislelizumab Combined With Anlotinib and Platinum-based Doublet Perioperative Therapy for Resectable Stage II-IIIB Driver Gene-negative NSCLC
NCT06977828NSCLC (Non-small Cell Lung Cancer), Neoadjuvant Immunotherapy, Adjuvant Immunotherapy
The First Affiliated Hospital with Nanjing Medical University
Phase 2
40
Nanjing
2025-07-20
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple-Ascending Doses of Tacabrutideg (BGB-16673) in Adults With Chronic Spontaneous Urticaria and in Healthy Participants
NCT07005713Chronic Spontaneous Urticaria
BeOne Medicines
Phase 1
58
Beijing, Chongqing, Guangzhou, Wuhan, Changsha, Qingdao, Chengdu, Hangzhou
2025-07-19
Recruiting
CD19 CAR-T Cell Infusion as Consolidation Therapy in Adolescent and Adult Patients With Acute B-ALL Ineligible for Allogeneic HSCT: A Clinical Study
NCT07072494Acute Lymphoblastic Leukemia
Zhujiang Hospital
Phase 1/2
30
Guangzhou
2025-07-19
Recruiting
Early Prophylactic Decompressive Hemicraniectomy Following Endovascular Therapy in Large Hemispheric Infarct Trial
NCT07118345Stroke, Ischemic, Cerebral Edema
Xuanwu Hospital, Beijing
Not applicable
380
Beijing, Shandong
2025-07-19
Recruiting
Safety & Efficacy of IR-101 in Relapsed/Refractory Neuroblastoma
NCT07067346Neuroblastoma
Sichuan University
Phase EARLY_PHASE1
10
Chengdu
2025-07-18
Recruiting
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
NCT06824168Acute Myeloid Leukemia, Leukemia
Daiichi Sankyo
Phase 2
130
Beijing, Changchun, Guangzhou, Hangzhou, Nanchang, Nanjing, Nanning, Qingdao
2025-07-18
Recruiting
A Study on the Treatment of Early Small Breast Cancer With Ultrasound-guided Vacuum-assisted Excision Combined With Surgery
NCT07071402Breast Cancer (Early Breast Cancer)
Xijing Hospital
Not applicable
120
Xi'an
2025-07-18
Active, closed
P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk
NCT06468033Primary Myelofibrosis, Myeloproliferative Neoplasm
PharmaEssentia
Phase 3
160
Beijing, Chongqing, Guangdong, Guangzhou, Harbin, Zhengzhou, Wuhan, Nanjing
2025-07-18
Recruiting
A Phase II Clinical Study of AK104/AK112 in Combination With TT-00420 Tablet for Advanced HCC.
NCT07052253Hepatocellular Carcinoma (HCC)
Akeso
Phase 2
100
Wuhan
2025-07-18
Not yet open
Outcomes of Sepsis Patients in China (CHINA-SEP)
NCT07066553Sepsis
Southeast University, China
Observational
5,775
Nanjing
2025-07-18
Recruiting
A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell Lymphoma
NCT07011056Recurrent and Refractory Diffuse Large B-cell Lymphoma
Chengdu Zenitar Biomedical Technology Co., Ltd
Phase 3
390
Chengdu
2025-07-18
Recruiting
A Study of SKB264 Versus Investigator's Choice of Chemotherapy in Subjects With Unresectable Locally Advanced, Relapsed, or Metastatic HR+/HER2- Breast Cancer Who Have Previously Failed Endocrine Therapy
NCT07071337Metastatic Breast Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 3
430
Beijing, Guangzhou
2025-07-18
Recruiting
A Phase I Study of SSGJ-612 in Patients With Advanced Solid Tumors
NCT07032298Advanced Malignant Tumors
Shenyang Sunshine Pharmaceutical Co., LTD.
Phase 1
30
Luoyang
2025-07-18
Recruiting
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
NCT06929273Bipolar Disorder Type I With Mania
Bristol-Myers Squibb
Phase 3
450
Beijing, Guangzhou, Baoding, Changsha, Nanjing, Xi'an, Chengdu, Tianjin
2025-07-18
Recruiting
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
NCT06953089Solid Tumors
DualityBio Inc.
Phase 2
450
Beijing, Dongguan, Henan, Xinxiang, Hubei, Wuhan, Changsha, Xuzhou
2025-07-18
Recruiting
Clinical Efficacy and Mechanism of tDCS for Dysphagia in PD
NCT07153692Parkinson's Disease and Parkinsonism, Dysphagia
Wang Ping
Not applicable
58
Hangzhou
2025-07-17
Recruiting
The Outcome of Chronic Kidney Disease Patients With Obstructive Sleep Apnea Syndrome
NCT06971874Chronic Kidney Diseases, OSAS (Obstructive Sleep Apneas Syndrome)
Nanfang Hospital, Southern Medical University
Observational
356
Guangzhou
2025-07-17
Recruiting
A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma
NCT07069712Gastroesophageal Adenocarcinoma
AstraZeneca
Phase 2
100
Beijing, Changchun, Changzhi, Chengdu, Fuzhou, Hangzhou, Kunming, Qingdao
2025-07-17
Recruiting
A Study of MHB046C Injection in Patients With Advanced Solid Tumors
NCT06985355Advanced Solid Cancer
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 1/2
200
Guangzhou
2025-07-17
Recruiting
DZD6008 Combination Therapy in Patients With Locally Advanced or Metastatic NSCLC With EGFR Mutation (TIAN-SHAN7)
NCT07070440Non Small Cell Lung Cancer
Dizal Pharmaceuticals
Phase 1/2
180
Shanghai
2025-07-16
Recruiting
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
NCT06997497Colon Adenocarcinoma, Rectal Adenocarcinoma
Merck Sharp & Dohme LLC
Phase 3
477
Hefei, Beijing, Chongqing, Wanzhou, Fuzhou, Xiamen, Guangzhou, Shenzhen
2025-07-16
Rows per page Showing 7001–7100 of 19052
Previous 69 70 71 72 73 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china?page=71

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.